Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

This Drug Just Gained "Blockbuster" Status – and There's Still Time to Hitch a Ride

Shares of blood-cancer drugmaker Pharmacyclics Inc. (Nasdaq: PCYC) rocketed as much as 22% on Tuesday after the company exhilarated investors by forecasting that sales of its key drug would double this year.

We weren't surprised by this, of course.

Full Story

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK